Alex Drysdale
Partner
British Virgin Islands
Alex advises corporates, private equity houses and financial institutions on a range of complex, cross-border corporate transactions.
These include mergers and acquisitions, capital raisings, joint ventures and corporate restructurings. He has acted on some of the most significant corporate transactions in the British Virgin Islands and is a go-to lawyer in the jurisdiction for public company work with a BVI nexus.
Alex has also advised on some of the jurisdictions most significant restructuring transactions including advising FTX in bankruptcy as part of its Chapter 11 proceedings as well as advising clients on complex debt restructurings pursuant to BVI schemes of arrangement.
Experience and recent work
Prior to joining Walkers, Alex worked in the corporate department at Clifford Chance for 10 years, in both their London and Sao Paulo offices. He also worked in-house for global mining company Anglo American.
Alex's experience includes:
- Advising Pfizer on its US$11.6 billion acquisition of NYSE-listed Biohaven Pharmaceuticals which represents the largest ever take private of a BVI company
Qualifications
Admitted in:
- British Virgin Islands
- England and Wales (not practising)
Education:
- MA Law, Cambridge University
- MA Management Studies, Judge Business School, Cambridge University
- LPC, College of Law London (Moorgate)
2023 Legal 500 - Recommended - Corporate & Commercial
2023 Legal 500 - Recommended - Investment Funds
Team Members
Other team members with related expertise
Matthew Cowman
Managing Partner
British Virgin Islands
Omonike Robinson-Pickering
Partner
British Virgin Islands
Lauren Williamson
Senior Associate
British Virgin Islands
